Stanley Druckenmiller (Duquesne Family Office) exit BRIDGEBIO PHARMA INC
Stanley Druckenmiller (Duquesne Family Office) exit $-15.1K of disclosed value in BRIDGEBIO PHARMA INC.
Signal
Investor Move
Action
Exit
Capital
$-15.1K disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.